s
Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease
02-07-2024, 13:54
SHANGHAI, July 2, 2024 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter clinical study exploring the percutaneous pulmonary artery denervation (PADN) treatment for pulmonary hypertension associated with left heart disease. This landmark […] L'articolo Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease proviene da La Ragione.
CONTINUA A LEGGERE
3
0
0
Guarda anche
La Ragione
00:43
Regno Unito, per gli exit poll larga vittoria dei Laburisti
La Ragione
Ieri, 22:43
Meloni “Il premierato rafforza il potere dei cittadini”
La Ragione
Ieri, 22:43
Palermo, Monti “Passi avanti verso il nuovo waterfront”
La Ragione
Ieri, 21:43
Palermo, Lagalla “Prosegue sinergia con l’Autorità portuale”
La Ragione
Ieri, 20:43
Palermo, con la passeggiata di Sant’Erasmo nuovo tratto del waterfront
La Ragione
Ieri, 20:43